|
|
|
Danaher Corp | 4.75% Mandatory Convertible Preferred Stock Series A (DHR.PRA)
Prospectus excerpt: We are offering 1,500,000 shares of our 4.75% Mandatory Convertible Preferred Stock, Series A, without par value (“Mandatory Convertible Preferred Stock”). Dividends on the Mandatory Convertible Preferred Stock will be payable on a cumulative basis when, as and if declared by our board of directors at an annual rate of 4.75% on the liquidation preference of $1,000 per share. We may pay declared dividends in cash or, subject to certain limitations, in shares of our common stock, par value $0.01 per share, or by delivery, at our election, of any combination of cash and shares of our common stock on January 15, April 15, July 15 and October 15 of each year, commencing on July 15, 2019, and to, and including, April 15, 2022. Full Prospectus PDF », Secondary Prospectus PDF », DHR Page »
Series: | A | Alternate symbology: | DHR-A, DHR-PA, DHRprA | Redeemable?: | Yes | Maturity Date: | 4/15/2022 | Cumulative?: | Yes | Conversion Ratio: | 6.6368-8.13 | Conversion Price: | $123-$150.68 | Shares Offered: | 1,500,000 | Liquidation Preference: | $1,000.00 | Original Coupon: | 4.75% | Pay Period: | Quarterly | Pay Dates: | 15-Jan, 15-Apr, 15-Jul, 15-Oct | CDx3 Compliance Rating: |
Learn DHR.PRA's Rating
|
|
Danaher designs, manufactures and markets medical, industrial and commercial products and services. Co.'s segments are: Biotechnology, which includes the bioprocessing and discovery and medical businesses and provides tools, consumables and services; Life Sciences, which provides instruments and consumables to understand the causes of disease, identify new therapies, and test and manufacture new drugs, vaccines and gene editing technologies; Diagnostics, which provides clinical instruments, reagents, consumables, software and services; and Environmental and Applied Solutions, which provides products and services that help protect resources and keep global food and water supplies safe. Preferreds: DHR.PRA, DHR.PRB Open the DHR Information Page »
|
Name: |
Danaher Corp |
Website: |
www.danaher.com |
Sector: |
Biotechnology |
Number of ETFs Holding DHR: |
97 (see which ones) |
Total Market Value Held by ETFs: |
$19,757,601,812.58 |
Total Market Capitalization: |
$185,475,000,000 |
% of Market Cap. Held by ETFs: |
10.65% |
|
|
|
|
|